TSLA

Tesla's Q3 2024 print catalyzed a violent repricing because three narratives converged simultaneously: margin recovery, FSD monetization optionality, and the sub-$30K vehicle roadmap for 2025. The EPS beat of $0.72 vs. $0.58 consensus demonstrated that cost efficiencies (raw materials, factory utilization, and operating leverage) are translating into real profitability even amid falling ASPs. Critically, automotive gross margin ex-credits rebounded above 17%, alleviating the bear thesis that Tesla is in a structural race to the bottom on pricing. The deeper institutional case for rerating lies in the sum-of-the-parts revaluation. Management explicitly framed 2025 as an inflection year with three product catalysts: the affordable model, Cybercab production path, and FSD supervised miles scaling toward unsupervised approval. Energy storage hit record deployments with 6.9 GWh, and that business is now on a $3B+ annualized revenue run rate with structurally higher margins than auto. Wall Street is beginning to price Tesla not as an automaker but as an AI/robotics platform with an attached cash-generating manufacturing business. The risk to sustained rerating is valuation. At ~80x forward earnings, Tesla already embeds enormous execution risk on robotaxi timelines, regulatory approval, and the affordable vehicle's production ramp. Any slippage on 2025 guidance or FSD milestones could trigger a sharp de-rating. However, the FCF recovery to $2.7B this quarter, combined with record energy margins and a clear product cadence, gives institutions enough fundamental cover to hold the gap and potentially extend gains into the January 2025 product update.

Analyzed by rules-v1-backfill · Jul 5, 2026

Outcomes calculated Jul 5, 2026